Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib.

Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib. Blood. 2012 Jul 12; 120(2):291-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.